FDMT
4D Molecular Therapeutics, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
4D Molecular Therapeutics (FDMT) Stock: Buy, Sell, or Hold?
$12.99
+0.53 (+4.25%)
▲
5d:
+5.78%
30d:
+5.1%
90d:
+11.5%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (65%)
Quality Score
54/100
Position
EXTENDED
30-Day Fair Range
$11.69 – $12.95
Position: EXTENDED
Forward P/E & Valuation
-3.2x
Next 12M consensus est.
Wall Street Target
$28.09
+116.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$11.16 / $13.46
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: FDMT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When FDMT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: FDMT is currently trading at $12.99, which is considered extended relative to its 30-day fair value range of $11.69 to $12.95.
Technical Outlook: Technically, FDMT is in a uptrend. Immediate support is located at $11.16, while resistance sits at $13.46. The stock is showing strong short-term momentum, up 4.3% recently.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $28.09 (+116.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, FDMT is in a uptrend. Immediate support is located at $11.16, while resistance sits at $13.46. The stock is showing strong short-term momentum, up 4.3% recently.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $28.09 (+116.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$11.69 -
$12.95
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
65.4%
Trading Range & Key Levels
30-Day Trading Range
$11.69 -
$12.95
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$0.69
(5.3%)
Support Level
$11.16
Resistance Level
$13.46
Current Trend
Uptrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (58/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.3%)
- BULLISH: Trading 116.3% below Wall St target ($28.09)
- NEUTRAL: Bottoming setup forming (58/100) — watch for confirmation
Fundamental Context
Forward P/E (Next Year Est.)
-3.17
Wall Street Target
$28.09
(+116.3%)
Revenue Growth (YoY)
25106.7%
Profit Margin
-194.7%
Share FDMT Analysis
Share this live FDMT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (FDMT)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jun 30, 2026
Daily AI digest
AI Retail Discussion Summary:
4DMT completes enrollment for 4FRONT-2 Phase 3 trial of 4D-150 in wet AMD, over-enrolled and ahead of schedule, with data expected in H2 2027.
Key Retail Themes:
Clinical trial progress
Enthusiasm from investors and retina physicians
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:19 AM ET
Data refreshes hourly during market hours. Next update: 3:19 AM
Data refreshes hourly during market hours. Next update: 3:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FDMT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 56 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 55 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 49 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 52 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$107 | 33 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive FDMT Research Pages
